View drug registration information details.


ItemsRegistration information
ID269
No269
Brand NameAZIMAX-250
IngredientsAZITHROMYCIN DIHYDRATE 262.05 MG EQ.TO AZITHROMYCIN 250 MG
Dosage FormFILM COATED TABLET
Primary PackagingBLISTERPACK
StorageSTORE BELOW 25 C, PROTECT FROM MOISTURE
Shelf Life3 YEARS
Pack SizeBOX OF 1 X 6'S, 5 X 6'S
Dispensing CategoryPrescription only
ATC ClassificationJ01FA10
Pharmaceutical ClassANTIBACTERIA
IndicationsBRONCHITIS, COMUNITY-ACQUIRED PNEUMONIA, SINUSITIS, PHARYNGITIS/TONSILITIS, OTITIS MEDIA, SKIN AND SOFT TISSUE INFECTION, UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS
ContraindicationsHYPERSENSITIVITY, RISK-BENEFIT SHOULD BE CONSIDERD WHEN HEPATIC FUNCTION IMPAIREMENT EXISTS BECAUSE BILLIARY EXCRETION IS THE MAJOR ROUTE OF ELIMINATION
Side EffectsGASTROINTESTINAL DISTURBANCE, TRANSIENT ELEVATIONS OF LIVER ENZYME VALUES, CHOLESTATIC JAUNDICE, RASHES, HEADACHE, DIZZINESS, TRANSIENT ALTERATIONS IN NEUTROPHIL
Unit Price1.63
EDL Yes
DescriptionOBLONG, WHITE FILM-COATED TABLET, BEVEL-EDGED, SHALLOW CONVEX WITH BREAK-BAR ON ONE SIDE AND HOVID EMBOSSED ON THE OTHER SIDE
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration NoMAL11090011AZ
Import Registration Date27/09/2016
ActivityCERTIFICATE RELEASED
Applied Date2022-04-08
FDD Registration No04 I 4686/19
FDD Registration Date2022-09-08
Expiry Date2025-09-07

Back to drug list